Lippincott ^® NursingCenter ^®

Featured Articles

• Buy

  AML Debating the Value of FLT3 Inhibitors

  Mark Fuerst

• Buy

  ASCO Grades Its 2011 Blueprint Report: How Much Progress?

  Sarah DiGiulio

• Buy

  ASCO Plenary Abstract 1 Glioblastoma—No Benefit for Added Bevacizumab Over Standard First-Line Chemo-RT

  Mark Fuerst

• Buy

  ASCO Plenary Abstract 2 Praise for Study Showing Feasibility of Reducing Cervical Cancer Rates in Developing Countries

  Mark Fuerst

• Buy

  ASCO Plenary Abstract 3 Cervical Cancer—Bevacizumab Extends Survival for Patients with Relapsed and Advanced Disease

  Mark Fuerst

• Buy

  Breast Cancer Self-reported Cognitive Complaints Shown to Align with Neuropsych Test Scores

  Sarah DiGiulio

• Buy

  Cancer-Related News from the CDC Antismoking Messages and Intention to Quit

  Roberta B. Caixeta et al.

• Buy

  Enhancing Care for Cancer Survivors in Rural Communities

  Heather Lindsey

• Buy

  Key Breast Cancer Takeaways from ASCO 2013

  Cynthia X. Ma MD, PhD

• Buy

  Key Colorectal Cancer Takeaways from ASCO 2013

  John L. Marshall MD